LAVA Therapeutics N.V. (LVTX) Tops Q2 EPS by 2c

LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q2 EPS of ($0.31), $0.02 better than the analyst estimate of ($0.33).

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• JPMorgan Upgrades Nanya Technology Corp (2408:TT) to Overweight
• Freedom Broker Starts Unity Bancorp (UNTY) at Hold